Contact

About Us

Founded in 1944, the American Committee for the Weizmann Institute of Science develops philanthropic support for the Weizmann Institute in Israel, and advances its mission of science for the benefit of humanity.

Our Achievements

The Weizmann Institute’s fundamental research has led to discoveries and applications with a major impact on the scientific community and on the quality of life for millions worldwide.

Get Involved

Join a community of dedicated people who share the Weizmann Institute’s commitment to shaping a better world through science.

News & Media

Learn about the Weizmann Institute’s latest groundbreaking discoveries and the American Committee’s activities across the country.

Blog

The Curiosity Review

Blog

Popular science for the curious-minded: The Curiosity Review brings discovery to life.

Fighting Coronavirus Donate

CORONAVIRUS

What is Weizmann Doing?

This special coronavirus section shares Weizmann Institute of Science research, expert opinion, education resources, and news. Our scientists are already conducting investigations that could improve testing and diagnosis techniques and provide new strategies for prevention and treatment – including a possible COVID-19 vaccine. We are committed to advancing research to protect and preserve the health and well-being of everyone, everywhere.

Learn more about our fight against Coronavirus

Coronavirus

Israeli Scientists Think They Know Why Virus is Severe for Some, Mild for Others

The Times of Israel

Prof. Ido Amit’s team is showing why COVID affects people so differently, reports The Times of Israel. The work could help pharmaceutical firms develop drugs by “providing a ‘target’ in the body for intervention.”

May 14, 2020

Coronavirus

Experts Find Link to Contracting Coronavirus and Socioeconomic Status

The Jerusalem Post

Prof. Eli Waxman heads a team that found people with less income and education are more likely to get COVID, reports The Jerusalem Post. The group advises Netanyahu on coronavirus.

May 13, 2020

Coronavirus

This Twist on the Four-Day Workweek Could Get People Back to Work Without Causing New Outbreaks

Fast Company

Fast Company covers the reopening strategy proposed by Prof. Uri Alon and Prof. Ron Milo, who says: “Our suggestion gives a predictable schedule that people can adapt to and builds confidence for people and the economy.”

May 12, 2020

Coronavirus

10-4: How to Reopen the Economy by Exploiting the Coronavirus’s Weak Spot

The New York Times

Profs. Uri Alon and Ron Milo write in The New York Times about their intermittent-work strategy to reopen society.

May 11, 2020

Coronavirus

Israeli Researchers Pinpoint What Happens to Seriously Ill Coronavirus Patients

Haaretz

As Haaretz reports, Prof. Ido Amit has found that the immune system plays a role in why some people get much sicker from COVID. He is now developing clinical studies to try and protect patients.

May 11, 2020

Coronavirus

How Often Do COVID-19 Patients Lose Their Sense of Smell? Two Studies Are Tracking Down the Data

Discover

Discover covers two studies – including Prof. Noam Sobel’s research – that are investigating how often people with COVID lose their sense of smell. The studies are seeking participants to take online tests.

May 11, 2020

Coronavirus

Maintaining Public Health Should not Mean the Death of Privacy, Says Turing Award Winner

CTECH

In this interview with CTECH, Prof. Shafi Goldwasser, who developed a tracking technology, talks about how important it is to monitor COVID’s spread—without violating individual privacy.

May 09, 2020

Coronavirus

COVID Moonshot: Can AI Algorithms and Volunteer Chemists Design a Knockout Antiviral?

IEEE Spectrum

Dr. Nir London helps head the “COVID Moonshot,” which involves academics, researchers, private firms, and the public, all working together on a coronavirus treatment. IEEE Spectrum reports.

May 08, 2020

Coronavirus

Could the Flu Become History? An Israeli Vaccine May Make It a Reality

Haaretz Magazine

Haaretz Magazine interviews Prof. Ruth Arnon, whose universal flu vaccine is on the cusp of approval. The vaccine will protect against multiple strains of flu for years with one shot, and is almost through clinical trials.

May 06, 2020

Prev 1 2 3 4 5 6 7 8 9 10 Next

MAKE A DONATION

Support the Fight Against the Coronavirus

Science is our best hope for ending the coronavirus crisis, and the Weizmann Institute is dedicated to finding the best ways to not only defeat this crisis quickly, but prevent future ones – now, we need your help.

Your gift supports our rapid response efforts and the brave and innovative scientists – the women and men on the front lines – who are tirelessly fighting the pandemic. Now is the time for all of us to take action.

Donate Now